semaglutide and urination Does Make You Pee a Lot? Urinary Side Effects Explained Is Frequent Urination a Side

Rosenkranz E, Maywald M, Hilgers RD, Brieger A, Clarner T, Kipp M, et al

But a Military Health System report published in January 2024 found that the number of active-duty service members who were prescribed a weight loss drug from January 2018 through June 2023 increased nearly a hundredfold, from 1.2 to 104.4 per 100,000 service members

[Accessed on 14th November 2022] 3

Clinical studies on GLP-1 receptor agonists, including Saxenda, Wegovy, Ozempic, and Mounjaro , provide valuable insight into their long-term efficacy: Saxenda (Liraglutide) A 3-year study showed: 56% of participants reached and maintained target weight loss in year one With continuous use, many maintained weight loss over 3 years Success was highest when paired with lifestyle interventions (diet + exercise) Risk of weight regain increased if Saxenda was discontinued without behavioral support Wegovy (Semaglutide) STEP 4 trial (68 weeks) showed: Patients who continued Wegovy maintained a 14.8% weight loss Those who stopped the medication regained about two-thirds of the weight within 1 year Suggests Wegovy is effective long-term , but requires ongoing treatment or strong lifestyle adherence Ozempic (Semaglutide) (used off-label for weight loss) In studies where Ozempic was used weekly: Weight loss was sustained as long as treatment continued Discontinuation led to partial weight regain , though not as rapid as in untreated individuals Works well when paired with structured eating plans Mounjaro (Tirzepatide) Strongest Long-Term Outcome to Date SURMOUNT-1 trial: After 72 weeks , participants lost up to 22.5% of body weight Even after treatment ended, those who adopted lifestyle changes were able to keep the weight off Its dual action on both GLP-1 and GIP receptors improves: Insulin sensitivity Appetite regulation Metabolism regulation Early data suggests Mounjaro has the lowest likelihood of rebound weight gain , especially when combined with follow-up care Comparing Saxenda, Wegovy, Ozempic, and Mounjaro 1

Assessment criteria were adapted based on organ-specific pathology: kidney sections were evaluated for tubular dilation, glomerular injury, and interstitial inflammation

Then, carefully unscrew the needle, remove it from the pen, and dispose of it in your sharps bin